SAB Biotherapeutics, Inc. (NASDAQ:SABS) Sees Large Decrease in Short Interest

SAB Biotherapeutics, Inc. (NASDAQ:SABS – Get Free Report) was the target of a significant decrease in short interest in the month of October. As of October 31st, there was short interest totalling 58,800 shares, a decrease of 26.3% from the October 15th total of 79,800 shares. Based on an average daily volume of 64,100 shares, […]

Leave a Reply

Your email address will not be published.

Previous post Valmet Oyj (OTCMKTS:VOYJF) Sees Large Decrease in Short Interest
Next post Parker: Unhappy Americans said ‘enough is enough’